13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001903793
Total reported value
$5.0B
$5.0B
10 檔
50.0%
At the close of Q4 2025, Tpg Gp A, LLC disclosed equity holdings valued at approximately $5.0B, spread across 10 reported holdings.
In Q4 2025, Tpg Gp A, LLC displayed an active expansion posture, initiating 1 new positions and adding to 0 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including LFST, LTH, BETA) accounted for 50.0% of total reported equity market value during Q4 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LFST | Lifestance Health Group Inc | Stock-Other | 42.11% | -0.32% | — | |
| 2 | LTH | Life Time Group Holdings Inc | Stock-Other | 17.64% | -6.61% | — | |
| 3 | BETA | Beta Technologies Inc -cl A | Stock-Other | 17.22% | -1.06% | — | |
| 4 | SION | Sionna Therapeutics Inc | Stock-Other | 10.33% | -1.37% | — | |
| 5 | AMRX | Amneal Pharmaceuticals Inc | Stock-Other | 5.78% | +0.10% | — | |
| 6 | CBLL | Ceribell Inc | Stock-Other | 3.24% | -0.52% | — | |
| 7 | BCAX | Bicara Therapeutics Inc | Stock-Other | 1.89% | +0.16% | — | |
| 8 | ALLO | Allogene Therapeutics Inc | Stock-Other | 0.95% | -0.46% | — | |
| 9 | TRTX | Tpg Re Finance Trust Inc | Stock-Other | 0.77% | -0.11% | — | |
| 10 | ✓ | Rallybio CORP | Stock-Other | 0.08% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CBLL | Ceribell Inc | +0.8% | — | Unchanged |
| 2 | ✓ | Rallybio CORP | — | — | Unchanged |
| 3 | ALLO | Allogene Therapeutics Inc | -0.3% | — | Unchanged |
| 4 | TRTX | Tpg Re Finance Trust Inc | -0.4% | — | Unchanged |
| 5 | SION | Sionna Therapeutics Inc | -0.5% | — | Unchanged |
| 6 | BCAX | Bicara Therapeutics Inc | -0.7% | — | Unchanged |
| 7 | AMRX | Amneal Pharmaceuticals Inc | -0.9% | — | Unchanged |
| 8 | LFST | Lifestance Health Group Inc | -6% | — | Unchanged |
| 9 | LTH | Life Time Group Holdings Inc | -9.2% | — | Unchanged |
| 10 | BETA | Beta Technologies Inc -cl A | — | NEW | New buy |
According to official SEC Form 13F filings, Tpg Gp A, LLC reported a total U.S. public equity portfolio value of $5.0B across 10 disclosed positions in Q4 2025.
During Q4 2025, Tpg Gp A, LLC's top holdings by market value included LFST (42.1%)、LTH (17.6%)、BETA (17.2%). The largest single position, LFST, represented 42.1% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
BETA
市值: $462.5M
In Q4 2025, Tpg Gp A, LLC made 1 total portfolio adjustments, initiating 1 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.